Magyar Bancorp, Inc.
MGYR Nasdaq Savings Institution, Federally Chartered Financials FY2016βFY2025
What Magyar Bancorp, Inc. does
No business description yet.
- Legal name
- Magyar Bancorp, Inc.
- Fiscal year ends
- September 30, 2025
- Latest annual report
- 10-K Β· Dec 19, 2025
- Accession Β· CIK
- 0002077096-25-000193
0001337068
Revenue and margins
Magyar Bancorp, Inc. had $31.9M of revenue in fiscal 2025, up 14.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 26.4% a year. Loss periods are shown in red.
Returns and efficiency
For banks, return on equity and the efficiency ratio (costs as a share of revenue) say most about how well the business runs.
Dividends, buybacks and share count
Magyar Bancorp, Inc. returned $1.8M to shareholders in fiscal 2025, 19% of free cash flow. The diluted share count fell 1.6%.
Balance sheet
Loans, deposits and capital at each fiscal year end.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Loans, net | $585M | $32.0M | $35.5M | β | β |
| Deposits | $640M | $668M | $755M | $797M | $814M |
| Loans / deposits | 91.5% | 4.8% | 4.7% | β | β |
| Total assets | $774M | $799M | $907M | $952M | $998M |
| Shareholders' equity | $97.6M | $98.5M | $105M | $111M | $119M |
| Provision / loans | 0.3% | 1.0% | 1.1% | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $19.1M | $20.2M | $21.8M | $22.5M | $23.1M | $29.0M | $29.7M | $30.4M | $28.0M | $31.9M |
| Net interest income | $16.9M | $18.2M | $19.7M | $20.4M | $21.4M | $25.6M | $27.0M | $27.7M | $28.0M | $31.9M |
| Noninterest income | $2.1M | $2.0M | $2.1M | $2.1M | $1.7M | $3.4M | $2.7M | $2.7M | β | β |
| Noninterest expense | $15.9M | $16.4M | $17.3M | $17.6M | $18.4M | $18.6M | $18.3M | $19.3M | β | β |
| Provision for credit losses | $1.4M | $1.3M | $1.0M | $0.7M | $1.7M | $1.6M | $0.3M | $0.4M | $0.1M | $0.4M |
| Interest expense | $3.5M | $3.8M | $4.6M | $6.7M | $5.5M | $2.9M | $2.5M | $10.3M | β | β |
| Pretax income | $1.8M | $2.4M | $3.5M | $4.3M | $3.1M | $8.7M | $11.2M | $10.7M | $11.1M | $13.8M |
| Income tax | $0.7M | $1.0M | $1.5M | $1.3M | $0.9M | $2.6M | $3.3M | $3.0M | $3.3M | $4.0M |
| Net income | $1.1M | $1.4M | $2.0M | $3.0M | $2.2M | $6.1M | $7.9M | $7.7M | $7.8M | $9.8M |
| Net income to common | $1.1M | $1.4M | $2.0M | β | β | $6.1M | $7.9M | β | β | β |
| Diluted EPS | $0.19 | $0.24 | $0.35 | $0.51 | $0.31 | $1.01 | $1.17 | $1.20 | $1.23 | $1.56 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $8.5M | $3.6M | $4.6M | $5.8M | $0.8M | $9.3M | $11.2M | $8.5M | $6.3M | $10.4M |
| Capital expenditure | $0.2M | $0.3M | $0.3M | $0.1M | $0.1M | $0.4M | $3.0M | β | $0.8M | $0.6M |
| Free cash flow | $8.3M | $3.3M | $4.3M | $5.7M | $0.7M | $8.8M | $8.2M | β | $5.5M | $9.8M |
| Depreciation and amortization | $0.8M | $0.8M | $0.9M | $0.9M | $0.9M | $0.8M | $0.8M | $0.8M | $0.9M | $0.9M |
| Stock-based compensation | $0.0M | β | β | β | β | β | $0.0M | $0.7M | $0.6M | $0.6M |
| Dividends paid | β | β | β | β | β | β | β | β | $1.7M | $1.8M |
| Dividends and buybacks | β | β | β | β | β | β | β | β | $1.7M | $1.8M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $21.8M | $22.3M | $15.4M | $21.5M | $67.8M | $75.2M | $30.9M | $72.5M | $25.6M | $7.1M |
| Total debt | β | β | β | $36.2M | $67.4M | $23.4M | $15.6M | $59.0M | $28.6M | $49.1M |
| Loans, net | $455M | $471M | $508M | $518M | $603M | $585M | $32.0M | $35.5M | β | β |
| Deposits | $493M | $515M | $530M | $530M | $618M | $640M | $668M | $755M | $797M | $814M |
| Property and equipment, net | $18.1M | $17.6M | $17.0M | $16.2M | $14.7M | $14.3M | $13.9M | $13.3M | $12.5M | $12.2M |
| Total assets | $584M | $603M | $624M | $630M | $754M | $774M | $799M | $907M | $952M | $998M |
| Total liabilities | $537M | $554M | $573M | $576M | $697M | $676M | $700M | $803M | $841M | $879M |
| Shareholders' equity | $47.7M | $49.5M | $51.4M | $54.7M | $56.9M | $97.6M | $98.5M | $105M | $111M | $119M |
| Margins | ||||||||||
| Net margin | 5.7% | 7.0% | 9.3% | 13.3% | 9.5% | 21.1% | 26.6% | 25.3% | 27.8% | 30.6% |
| FCF margin | 43.7% | 16.3% | 19.9% | 25.5% | 2.9% | 30.5% | 27.6% | β | 19.7% | 30.8% |
| Net interest share of revenue | 88.7% | 90.1% | 90.3% | 90.5% | 92.6% | 88.2% | 90.9% | 91.2% | 100.0% | 100.0% |
| Efficiency ratio | 83.6% | 81.4% | 79.4% | 78.1% | 79.3% | 64.3% | 61.4% | 63.4% | β | β |
| Returns | ||||||||||
| Return on equity | 2.3% | 2.9% | 4.0% | 5.7% | 3.9% | 7.9% | 8.1% | 7.6% | 7.2% | 8.5% |
| Return on assets | 0.2% | 0.2% | 0.3% | 0.5% | 0.3% | 0.8% | 1.0% | 0.9% | 0.8% | 1.0% |
| Return on tangible equity | 2.3% | 2.9% | 4.0% | 5.5% | 3.9% | 6.3% | 8.0% | 7.4% | 7.0% | 8.2% |
| Growth | ||||||||||
| Revenue growth | β | 6.0% | 8.0% | 3.2% | 2.7% | 25.4% | 2.5% | 2.3% | β8.0% | 14.0% |
| Net income growth | β | 30.4% | 42.7% | 47.6% | β26.9% | 179.5% | 29.4% | β2.7% | 1.0% | 25.4% |
| EPS growth | β | 26.3% | 45.8% | 45.7% | β39.2% | 225.8% | 15.8% | 2.6% | 2.5% | 26.8% |
| FCF growth | β | β60.4% | 31.4% | 32.2% | β88.4% | 1,225.2% | β7.2% | β | β | 78.3% |
| Share count change | β | 0.0% | 0.0% | 0.0% | 22.1% | β15.0% | 12.3% | β5.3% | β1.3% | β1.6% |
| Financial health | ||||||||||
| Debt / equity | β | β | β | 0.7x | 1.2x | 0.2x | 0.2x | 0.6x | 0.3x | 0.4x |
| Loans / deposits | 92.4% | 91.4% | 95.9% | 97.8% | 97.5% | 91.5% | 4.8% | 4.7% | β | β |
| Provision / loans | 0.3% | 0.3% | 0.2% | 0.1% | 0.3% | 0.3% | 1.0% | 1.1% | β | β |
| Capital allocation | ||||||||||
| Capex / revenue | 1.0% | 1.5% | 1.3% | 0.2% | 0.6% | 1.4% | 10.1% | β | 2.9% | 1.8% |
| Stock comp / revenue | 0.0% | β | β | β | β | β | 0.0% | 2.2% | 2.3% | 1.9% |
| Payouts / FCF | β | β | β | β | β | β | β | β | 30.5% | 18.6% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | β | 2.0 | 7.0 | 5.0 | 4.0 | 4.0 | 6.0 |
| Accruals ratio | β1.3% | β0.4% | β0.4% | β0.4% | 0.2% | β0.4% | β0.4% | β0.1% | 0.2% | β0.1% |
Source: SEC EDGAR XBRL filings (CIK 0001337068). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.